<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37145350</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2161-3311</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Current nutrition reports</Title><ISOAbbreviation>Curr Nutr Rep</ISOAbbreviation></Journal><ArticleTitle>A Narrative Review on the Potential Role of Vitamin D<sub>3</sub> in the Prevention, Protection, and Disease Mitigation of Acute and Long COVID-19.</ArticleTitle><Pagination><StartPage>215</StartPage><EndPage>223</EndPage><MedlinePgn>215-223</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s13668-023-00471-2</ELocationID><Abstract><AbstractText Label="PURPOSE OF REVIEW">The coronavirus disease 2019 (COVID-19) pandemic has challenged global health systems and economies from January 2020. COVID-19 caused by the infectious severe acute respiratory syndrome coronavirus (SARS-CoV-2) has acute respiratory and cardiometabolic symptoms that can be severe and lethal. Long-term physiological and psychological symptoms, known as long COVID-19, persist affecting multiple organ systems. While vaccinations support the fight against SARS-CoV-2, other effective mechanisms of population protection should exist given the presence of yet unvaccinated and at-risk vulnerable groups, global disease comorbidities, and short-lived vaccine responses. The review proposes vitamin D<sub>3</sub> as a plausible molecule for prevention, protection, and disease mitigation of acute and long COVID-19.</AbstractText><AbstractText Label="RECENT FINDINGS">Epidemiological studies have shown that individuals who were deficient in vitamin D<sub>3</sub> had worse COVID-19 health outcomes and mortality rates. Higher doses of vitamin D<sub>3</sub> supplementation may improve health and survivorship in individuals of various age groups, comorbidities, and severity of disease symptoms. Vitamin D<sub>3</sub>'s biological effects can provide protection and repair in multiple organ systems affected by SARS-CoV-2. Vitamin D<sub>3</sub> supplementation can potentially support disease-mitigation in acute and long COVID-19.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Moukayed</LastName><ForeName>Meis</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-3951-7712</Identifier><AffiliationInfo><Affiliation>School of Arts and Sciences, American University in Dubai, Al Asad Street, PO Box 28282, Dubai, United Arab Emirates. mmoukayed@hotmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Curr Nutr Rep</MedlineTA><NlmUniqueID>101587480</NlmUniqueID><ISSNLinking>2161-3311</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>1C6V77QF41</RegistryNumber><NameOfSubstance UI="D002762">Cholecalciferol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002762" MajorTopicYN="N">Cholecalciferol</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long COVID-19</Keyword><Keyword MajorTopicYN="N">Public health benefits</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Vitamin D</Keyword></KeywordList><CoiStatement>None to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>5</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>5</Day><Hour>11</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37145350</ArticleId><ArticleId IdType="pmc">PMC10161182</ArticleId><ArticleId IdType="doi">10.1007/s13668-023-00471-2</ArticleId><ArticleId IdType="pii">10.1007/s13668-023-00471-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO. WHO Coronavirus dashboard. https://covid19.who.int/. Accessed 2 Apr 2023.</Citation></Reference><Reference><Citation>Yeyati EL, Filippini F. Social and economic impact of COVID-19. In: The Independent Panel of the World Health Organization, editor. Brookings global working paper #158. Brookings Institution; 2021.</Citation></Reference><Reference><Citation>The World Bank . Global economic prospects. Washington, DC: The World Bank; 2021. Subdued global economic recovery.</Citation></Reference><Reference><Citation>Robinson LA. COVID-19 and uncertainties in the value per statistical life. The Regulatory Review; 2020.</Citation></Reference><Reference><Citation>Ye ZW, Yuan S, Yuen KS, Fung SY, Chan CP, Jin DY. Zoonotic origins of human coronaviruses. Int J Biol Sci. 2020;16(10):1686&#x2013;1697. doi: 10.7150/ijbs.45472.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.45472</ArticleId><ArticleId IdType="pmc">PMC7098031</ArticleId><ArticleId IdType="pubmed">32226286</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19(3):141&#x2013;154. doi: 10.1038/s41579-020-00459-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-020-00459-7</ArticleId><ArticleId IdType="pmc">PMC7537588</ArticleId><ArticleId IdType="pubmed">33024307</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B, Tian EK, He B, Tian L, Han R, Wang S, et al. Overview of lethal human coronaviruses. Signal Transduct Target Ther. 2020;5(1):89. doi: 10.1038/s41392-020-0190-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-0190-2</ArticleId><ArticleId IdType="pmc">PMC7289715</ArticleId><ArticleId IdType="pubmed">32533062</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahimi A, Mirzazadeh A, Tavakolpour S. Genetics and genomics of SARS-CoV-2: A review of the literature with the special focus on genetic diversity and SARS-CoV-2 genome detection. Genomics. 2021;113(1 Pt 2):1221&#x2013;1232. doi: 10.1016/j.ygeno.2020.09.059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ygeno.2020.09.059</ArticleId><ArticleId IdType="pmc">PMC7525243</ArticleId><ArticleId IdType="pubmed">33007398</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271&#x2013;280. doi: 10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO . Coronavirus disease (COVID-19) weekly epidemiological update and weekly operational update. World Health Organization; 2022.</Citation></Reference><Reference><Citation>&#x2022; Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497&#x2013;506. 10.1016/S0140-6736(20)30183-5.&#xa0;This is one the first seminal descriptions of clinical features of patients with acute COVID-19 emerging from China at the beginning of the pandemic.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva Andrade B, Siqueira S, de Assis Soares WR, de Souza Rangel F, Santos NO, Dos Santos Freitas A, et al. Long-COVID and Post-COVID health complications: an up-to-date review on clinical conditions and their possible molecular mechanisms. Viruses. 2021;13(4):700. doi: 10.3390/v13040700.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13040700</ArticleId><ArticleId IdType="pmc">PMC8072585</ArticleId><ArticleId IdType="pubmed">33919537</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Olama M, Rashid A, Garozzo D. COVID-19-associated meningoencephalitis complicated with intracranial hemorrhage: a case report. Acta Neurochir. 2020;162(7):1495&#x2013;1499. doi: 10.1007/s00701-020-04402-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00701-020-04402-w</ArticleId><ArticleId IdType="pmc">PMC7237227</ArticleId><ArticleId IdType="pubmed">32430637</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathish T, Cao Y, Kapoor N. Newly diagnosed diabetes in COVID-19 patients. Prim Care Diabetes. 2021;15(1):194. doi: 10.1016/j.pcd.2020.08.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pcd.2020.08.014</ArticleId><ArticleId IdType="pmc">PMC7451214</ArticleId><ArticleId IdType="pubmed">32900656</ArticleId></ArticleIdList></Reference><Reference><Citation>Sierpina VS. Become aware of the short and long-term mental health effects of COVID. Explore. 2021;17(4):281. doi: 10.1016/j.explore.2021.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.explore.2021.04.008</ArticleId><ArticleId IdType="pmc">PMC8088040</ArticleId><ArticleId IdType="pubmed">34127397</ArticleId></ArticleIdList></Reference><Reference><Citation>Gemelli Against C-P-ACSG Post-COVID-19 global health strategies: the need for an interdisciplinary approach. Aging Clin Exp Res. 2020;32(8):1613&#x2013;1620. doi: 10.1007/s40520-020-01616-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40520-020-01616-x</ArticleId><ArticleId IdType="pmc">PMC7287410</ArticleId><ArticleId IdType="pubmed">32529595</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022; Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11(1):16144. 10.1038/s41598-021-95565-8. This systematic review details more than 50 long COVID-19 complications reported.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi A, Bernabei R, Landi F, Gemelli Against C-P-ACSG Persistent symptoms in patients after acute COVID-19. Jama. 2020;324(6):603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M, Halpin S, Hollingworth L, Snook N, Hickman K, Clifton IJ. Development of an integrated rehabilitation pathway for individuals recovering from COVID-19 in the community. J Rehab Med. 2020;52(8):jrm00089. doi: 10.2340/16501977-2727.</Citation><ArticleIdList><ArticleId IdType="doi">10.2340/16501977-2727</ArticleId><ArticleId IdType="pubmed">32830284</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg MK, Gopalakrishnan M, Yadav P, Misra S. Endocrine involvement in COVID-19: mechanisms, clinical features, and implications for care. Indian J Endocrinol Metab. 2020;24(5):381&#x2013;386. doi: 10.4103/ijem.IJEM_440_20.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijem.IJEM_440_20</ArticleId><ArticleId IdType="pmc">PMC7810055</ArticleId><ArticleId IdType="pubmed">33489841</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022; Thompson EJ, Williams DM, Walker AJ, Mitchell RE, Niedzwiedz CL, Yang TC, et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat Commun. 2022;13(1):3528. 10.1038/s41467-022-30836-0. This paper reviews long COVID-19 disease burden and risk factors available from 10 UK longtitudinal studies.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Li MY, Li L, Zhang Y, Wang XS. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty. 2020;9(1):45. doi: 10.1186/s40249-020-00662-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40249-020-00662-x</ArticleId><ArticleId IdType="pmc">PMC7186534</ArticleId><ArticleId IdType="pubmed">32345362</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggerly CA, Cuomo RE, French CB, Garland CF, Gorham ED, Grant WB, et al. Sunlight and Vitamin D: necessary for public health. J Am Coll Nutr. 2015;34(4):359&#x2013;365. doi: 10.1080/07315724.2015.1039866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07315724.2015.1039866</ArticleId><ArticleId IdType="pmc">PMC4536937</ArticleId><ArticleId IdType="pubmed">26098394</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022; Dominguez LJ, Farruggia M, Veronese N, Barbagallo M. Vitamin D sources, metabolism, and deficiency: available compounds and guidelines for its treatment. Metabolites. 2021;11(4). 10.3390/metabo11040255. This represents a current critical review of vitamin D3sources, metabolism and deficiency.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8074587</ArticleId><ArticleId IdType="pubmed">33924215</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022; Heaney RP, Holick MF. Why the IOM recommendations for vitamin D are deficient. J Bone Miner Res Off J Am Soc Bone Miner Res. 2011;26(3):455&#x2013;7. 10.1002/jbmr.328. While not recent, this is one of the key papers which initiated the debate of why vitamin D3IOM levels are majorly underestimated and need revision.</Citation><ArticleIdList><ArticleId IdType="pubmed">21337617</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadimitriou DT. The big Vitamin D mistake. J Prev Med Public Health. 2017;50(4):278&#x2013;281. doi: 10.3961/jpmph.16.111.</Citation><ArticleIdList><ArticleId IdType="doi">10.3961/jpmph.16.111</ArticleId><ArticleId IdType="pmc">PMC5541280</ArticleId><ArticleId IdType="pubmed">28768407</ArticleId></ArticleIdList></Reference><Reference><Citation>LeBlanc ES, Zakher B, Daeges M, Pappas M, Chou R. Screening for vitamin D deficiency: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2015;162(2):109&#x2013;122. doi: 10.7326/M14-1659.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M14-1659</ArticleId><ArticleId IdType="pubmed">25419719</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022; Moukayed M, Grant WB. Linking the metabolic syndrome and obesity with vitamin D status: risks and opportunities for improving cardiometabolic health and well-being. Diabetes Metab Syndr Obes Targets Ther. 2019;12:1437&#x2013;47. 10.2147/DMSO.S176933. This paper reviews the role of vitamin D3in mitigating cardiometabolic risk factors.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6701609</ArticleId><ArticleId IdType="pubmed">31496777</ArticleId></ArticleIdList></Reference><Reference><Citation>L Bishop E, Ismailova A, Dimeloe S, Hewison M, White JH. Vitamin D and immune regulation: antibacterial, antiviral, anti-inflammatory. JBMR Plus. 2021;5(1):e10405. doi: 10.1002/jbm4.10405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbm4.10405</ArticleId><ArticleId IdType="pmc">PMC7461279</ArticleId><ArticleId IdType="pubmed">32904944</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilani SJ, Bin-Jumah MN, Nadeem MS, Kazmi I. Vitamin D attenuates COVID-19 complications via modulation of proinflammatory cytokines, antiviral proteins, and autophagy. Expert Rev Anti Infect Ther. 2022;20(2):231&#x2013;241. doi: 10.1080/14787210.2021.1941871.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14787210.2021.1941871</ArticleId><ArticleId IdType="pmc">PMC8477590</ArticleId><ArticleId IdType="pubmed">34112047</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed F. A network-based analysis reveals the mechanism underlying vitamin D in suppressing cytokine storm and virus in SARS-CoV-2 infection. Front Immunol. 2020;11:590459. doi: 10.3389/fimmu.2020.590459.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.590459</ArticleId><ArticleId IdType="pmc">PMC7756074</ArticleId><ArticleId IdType="pubmed">33362771</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022; Peng MY, Liu WC, Zheng JQ, Lu CL, Hou YC, Zheng CM, et al. Immunological aspects of SARS-CoV-2 infection and the putative beneficial role of Vitamin-D. Int J Mol Sci. 2021;22(10). 10.3390/ijms22105251. This review highlights the important immunomodulatory role of vitamin D3in SARS-CoV-2 affected individuals.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8155889</ArticleId><ArticleId IdType="pubmed">34065735</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee C. Controversial effects of Vitamin D and related genes on viral infections, pathogenesis, and treatment outcomes. Nutrients. 2020;12(4):962. doi: 10.3390/nu12040962.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12040962</ArticleId><ArticleId IdType="pmc">PMC7230640</ArticleId><ArticleId IdType="pubmed">32235600</ArticleId></ArticleIdList></Reference><Reference><Citation>Crafa A, Cannarella R, Condorelli RA, Mongioi LM, Barbagallo F, Aversa A, et al. Influence of 25-hydroxy-cholecalciferol levels on SARS-CoV-2 infection and COVID-19 severity: a systematic review and meta-analysis. EClinicalMedicine. 2021;37:100967. doi: 10.1016/j.eclinm.2021.100967.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.100967</ArticleId><ArticleId IdType="pmc">PMC8215557</ArticleId><ArticleId IdType="pubmed">34179737</ArticleId></ArticleIdList></Reference><Reference><Citation>Israel A, Cicurel A, Feldhamer I, Stern F, Dror Y, Giveon SM, et al. Vitamin D deficiency is associated with higher risks for SARS-CoV-2 infection and COVID-19 severity: a retrospective case-control study. Intern Emerg Med. 2022;17(4):1053&#x2013;1063. doi: 10.1007/s11739-021-02902-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-021-02902-w</ArticleId><ArticleId IdType="pmc">PMC8742718</ArticleId><ArticleId IdType="pubmed">35000118</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufman HW, Niles JK, Kroll MH, Bi C, Holick MF. SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels. PloS one. 2020;15(9):e0239252. doi: 10.1371/journal.pone.0239252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0239252</ArticleId><ArticleId IdType="pmc">PMC7498100</ArticleId><ArticleId IdType="pubmed">32941512</ArticleId></ArticleIdList></Reference><Reference><Citation>Sulli A, Gotelli E, Casabella A, Paolino S, Pizzorni C, Alessandri E, et al. Vitamin D and lung outcomes in elderly COVID-19 patients. Nutrients. 2021;13(3):717. doi: 10.3390/nu13030717.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13030717</ArticleId><ArticleId IdType="pmc">PMC7996150</ArticleId><ArticleId IdType="pubmed">33668240</ArticleId></ArticleIdList></Reference><Reference><Citation>Annweiler C, Beaudenon M, Gautier J, Simon R, Dubee V, Gonsard J, et al. Covid-19 and high-dose VITamin D supplementation TRIAL in high-risk older patients (COVIT-TRIAL): study protocol for a randomized controlled trial. Trials. 2020;21(1):1031. doi: 10.1186/s13063-020-04928-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-020-04928-5</ArticleId><ArticleId IdType="pmc">PMC7768266</ArticleId><ArticleId IdType="pubmed">33371905</ArticleId></ArticleIdList></Reference><Reference><Citation>Annweiler G, Corvaisier M, Gautier J, Dubee V, Legrand E, Sacco G, et al. Vitamin D supplementation associated to better survival in hospitalized frail elderly COVID-19 patients: the GERIA-COVID quasi-experimental study. Nutrients. 2020;12(11):3377. doi: 10.3390/nu12113377.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12113377</ArticleId><ArticleId IdType="pmc">PMC7693938</ArticleId><ArticleId IdType="pubmed">33147894</ArticleId></ArticleIdList></Reference><Reference><Citation>Entrenas Castillo M, Entrenas Costa LM, Vaquero Barrios JM, Alcala Diaz JF, Lopez Miranda J, Bouillon R, et al. Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: a pilot randomized clinical study. J Steroid Biochem Mol Biol. 2020;203:105751. doi: 10.1016/j.jsbmb.2020.105751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsbmb.2020.105751</ArticleId><ArticleId IdType="pmc">PMC7456194</ArticleId><ArticleId IdType="pubmed">32871238</ArticleId></ArticleIdList></Reference><Reference><Citation>Abroug H, Maatouk A, Bennasrallah C, Dhouib W, Ben Fredj M, Zemni I, et al. Effect of vitamin D supplementation versus placebo on recovery delay among COVID-19 Tunisian patients: a randomized-controlled clinical trial. Trials. 2023;24(1):123. doi: 10.1186/s13063-023-07114-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-023-07114-5</ArticleId><ArticleId IdType="pmc">PMC9940050</ArticleId><ArticleId IdType="pubmed">36803273</ArticleId></ArticleIdList></Reference><Reference><Citation>Murai IH, Fernandes AL, Sales LP, Pinto AJ, Goessler KF, Duran CSC, et al. Effect of a single high dose of Vitamin D3 on hospital length of stay in patients with moderate to severe COVID-19: a randomized clinical trial. JAMA. 2021;325(11):1053&#x2013;1060. doi: 10.1001/jama.2020.26848.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.26848</ArticleId><ArticleId IdType="pmc">PMC7890452</ArticleId><ArticleId IdType="pubmed">33595634</ArticleId></ArticleIdList></Reference><Reference><Citation>Jevalikar G, Mithal A, Singh A, Sharma R, Farooqui KJ, Mahendru S, et al. Lack of association of baseline 25-hydroxyvitamin D levels with disease severity and mortality in Indian patients hospitalized for COVID-19. Sci Rep. 2021;11(1):6258. doi: 10.1038/s41598-021-85809-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-85809-y</ArticleId><ArticleId IdType="pmc">PMC7973709</ArticleId><ArticleId IdType="pubmed">33737631</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022; Ghelani D, Alesi S, Mousa A. Vitamin D and COVID-19: an overview of recent evidence. Int J Mol Sci. 2021;22(19). 10.3390/ijms221910559. Excellent current review evaluating the epidemiological studies regarding the association between vitamin D3 and COVID-19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8509048</ArticleId><ArticleId IdType="pubmed">34638897</ArticleId></ArticleIdList></Reference><Reference><Citation>Alcala-Diaz JF, Limia-Perez L, Gomez-Huelgas R, Martin-Escalante MD, Cortes-Rodriguez B, Zambrana-Garcia JL, et al. Calcifediol treatment and hospital mortality due to COVID-19: a cohort study. Nutrients. 2021;13(6):1760. doi: 10.3390/nu13061760.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13061760</ArticleId><ArticleId IdType="pmc">PMC8224356</ArticleId><ArticleId IdType="pubmed">34064175</ArticleId></ArticleIdList></Reference><Reference><Citation>Annweiler C, Beaudenon M, Gautier J, Gonsard J, Boucher S, Chapelet G, et al. High-dose versus standard-dose vitamin D supplementation in older adults with COVID-19 (COVIT-TRIAL): a multicenter, open-label, randomized controlled superiority trial. PLoS Med. 2022;19(5):e1003999. doi: 10.1371/journal.pmed.1003999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003999</ArticleId><ArticleId IdType="pmc">PMC9154122</ArticleId><ArticleId IdType="pubmed">35639792</ArticleId></ArticleIdList></Reference><Reference><Citation>Karonova TL, Chernikova AT, Golovatyuk KA, Bykova ES, Grant WB, Kalinina OV, et al. Vitamin D intake may reduce SARS-CoV-2 infection morbidity in health care workers. Nutrients. 2022;14(3):505. doi: 10.3390/nu14030505.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14030505</ArticleId><ArticleId IdType="pmc">PMC8839300</ArticleId><ArticleId IdType="pubmed">35276863</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022; Shah K, Varna VP, Sharma U, Mavalankar D. Does vitamin D supplementation reduce COVID-19 severity?: a systematic review. QJM: monthly journal of the Association of Physicians. 2022;115(10):665&#x2013;72. 10.1093/qjmed/hcac040. Excellent current review evaluating the epidemiological studies regarding the association between vitamin D3 and COVID-19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9383458</ArticleId><ArticleId IdType="pubmed">35166850</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenzel J, Schwaninger M. How COVID-19 affects microvessels in the brain. Brain J Neurol. 2022;145(7):2242&#x2013;2244. doi: 10.1093/brain/awac211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac211</ArticleId><ArticleId IdType="pmc">PMC9337801</ArticleId><ArticleId IdType="pubmed">35848856</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MH, Perl DP, Nair G, Li W, Maric D, Murray H, et al. Microvascular Injury in the Brains of Patients with Covid-19. N Engl J Med. 2021;384(5):481&#x2013;483. doi: 10.1056/NEJMc2033369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2033369</ArticleId><ArticleId IdType="pmc">PMC7787217</ArticleId><ArticleId IdType="pubmed">33378608</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022; Marek K, Cichon N, Saluk-Bijak J, Bijak M, Miller E. The role of vitamin D in stroke prevention and the effects of its supplementation for post-stroke rehabilitation: a narrative review. Nutrients. 2022;14(13). 10.3390/nu14132761. This review beautifully presents current findings into the capability of vitamin D3in in brain repair and function even after injury. Vitamin D3therefore can have a long term therapeutic potential in long COVID-19 brain related dysfunctions.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9268813</ArticleId><ArticleId IdType="pubmed">35807941</ArticleId></ArticleIdList></Reference><Reference><Citation>Aspell N, Lawlor B, O'Sullivan M. Is there a role for vitamin D in supporting cognitive function as we age? Proc Nutr Soc. 2018;77(2):124&#x2013;134. doi: 10.1017/S0029665117004153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0029665117004153</ArticleId><ArticleId IdType="pubmed">29233204</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W, Zhu DM, Li S, Cui S, Jiang P, Wang R, et al. The reduction of vitamin D in females with major depressive disorder is associated with worse cognition mediated by abnormal brain functional connectivity. Prog Neuropsychopharmacol Biol Psychiatry. 2022;118:110577. doi: 10.1016/j.pnpbp.2022.110577.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pnpbp.2022.110577</ArticleId><ArticleId IdType="pubmed">35605842</ArticleId></ArticleIdList></Reference><Reference><Citation>DeLuca GC, Kimball SM, Kolasinski J, Ramagopalan SV, Ebers GC. Review: the role of vitamin D in nervous system health and disease. Neuropathol Appl Neurobiol. 2013;39(5):458&#x2013;484. doi: 10.1111/nan.12020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12020</ArticleId><ArticleId IdType="pubmed">23336971</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo C, Valle MS, Casabona A, Spicuzza L, Sambataro G, Malaguarnera L. Vitamin D impacts on skeletal muscle dysfunction in patients with COPD promoting mitochondrial health. Biomedicines. 2022;10(4):898. doi: 10.3390/biomedicines10040898.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10040898</ArticleId><ArticleId IdType="pmc">PMC9026965</ArticleId><ArticleId IdType="pubmed">35453648</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022; Tomlinson PB, Joseph C, Angioi M. Effects of vitamin D supplementation on upper and lower body muscle strength levels in healthy individuals. A systematic review with meta-analysis. J Sci Med Sport. 2015;18(5):575&#x2013;80. 10.1016/j.jsams.2014.07.022. A systematic review demonstrating the important role of vitamin D3in muscle regeneration. Muscle repair and regeneration is important in tackling myalgia, fatigue and other related complications of long COVID-19.</Citation><ArticleIdList><ArticleId IdType="pubmed">25156880</ArticleId></ArticleIdList></Reference><Reference><Citation>Latham CM, Brightwell CR, Keeble AR, Munson BD, Thomas NT, Zagzoog AM, et al. Vitamin D promotes skeletal muscle regeneration and mitochondrial health. Front Physiol. 2021;12:660498. doi: 10.3389/fphys.2021.660498.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2021.660498</ArticleId><ArticleId IdType="pmc">PMC8079814</ArticleId><ArticleId IdType="pubmed">33935807</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan CW, Ho LP, Kalimuddin S, Cherng BPZ, Teh YE, Thien SY, et al. Cohort study to evaluate the effect of vitamin D, magnesium, and vitamin B12 in combination on progression to severe outcomes in older patients with coronavirus (COVID-19) Nutrition. 2020;79:111017. doi: 10.1016/j.nut.2020.111017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2020.111017</ArticleId><ArticleId IdType="pmc">PMC7832811</ArticleId><ArticleId IdType="pubmed">33039952</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022; McCullough PJ, Lehrer DS, Amend J. Daily oral dosing of vitamin D3 using 5000 TO 50,000 international units a day in long-term hospitalized patients: insights from a seven year experience. J Steroid Biochem Mol Biol. 2019;189:228&#x2013;39. 10.1016/j.jsbmb.2018.12.010. This study clearly emphasizes that higher vitamin D3doses can be administered to improve health outcomes and reduce hospitalization in patients without concerns of putative vitamin D side-effects.</Citation><ArticleIdList><ArticleId IdType="pubmed">30611908</ArticleId></ArticleIdList></Reference><Reference><Citation>Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000;72(3):690&#x2013;693. doi: 10.1093/ajcn/72.3.690.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/72.3.690</ArticleId><ArticleId IdType="pubmed">10966885</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant WB, Boucher BJ, Al Anouti F, Pilz S. Comparing the evidence from observational studies and randomized controlled trials for nonskeletal health effects of vitamin D. Nutrients. 2022;14(18):3811. doi: 10.3390/nu14183811.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14183811</ArticleId><ArticleId IdType="pmc">PMC9501276</ArticleId><ArticleId IdType="pubmed">36145186</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>